SEC Form 4 · accession 0001225208-26-006748
EQUIFAX INC · EFX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark W Begor
Officer — CEO · Director
Period of report
Jul 24, 2026
Accepted (ET)
Jul 28, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000033185
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 24, 2026 | M | 37,791 | $112.46 | A | 309,681 | D | |
| Common StockF3,F2 | Jul 24, 2026 | S | 500 | $175.852 | D | 309,181 | D | |
| Common StockF4,F2 | Jul 24, 2026 | S | 600 | $169.8583 | D | 308,581 | D | |
| Common StockF5,F2 | Jul 24, 2026 | S | 600 | $168.4747 | D | 307,981 | D | |
| Common StockF6,F2 | Jul 24, 2026 | S | 1,300 | $174.9123 | D | 306,681 | D | |
| Common StockF7,F2 | Jul 24, 2026 | S | 2,936 | $173.7877 | D | 303,745 | D | |
| Common StockF8,F2 | Jul 24, 2026 | S | 4,112 | $172.79 | D | 299,633 | D | |
| Common StockF9,F2 | Jul 24, 2026 | S | 6,200 | $171.2619 | D | 293,433 | D | |
| Common StockF10,F2 | Jul 24, 2026 | S | 21,543 | $171.9986 | D | 271,890 | D | |
| Common Stock | holding | — | — | — | 2,350 | I | 2-yr Apr 2025 GRAT | |
| Common Stock | holding | — | — | — | 21,284 | I | 2-yr Dec 2025 GRAT | |
| Common Stock | holding | — | — | — | 38,332 | I | 2-yr Jun 2025 GRAT | |
| Common Stock | holding | — | — | — | 2,018 | I | 2-yr May 2025 GRAT | |
| Common Stock | holding | — | — | — | 18,562 | I | 2-yr May 2026 GRAT |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option/Right to BuyF11 | $112.46 | Jul 24, 2026 | M | 37,791 | D | — | May 4, 2028 | Common Stock | 37,791 | 37,792 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/28/2025.
- F10The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $171.50 to $172.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F11The option vested in three equal annual increments beginning 5/4/2019.
- F2Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
- F3The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $175.74 to $175.94, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F4The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $169.42 to $170.09, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F5The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $168.395 to $168.55, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F6The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $174.54 to $175.48, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F7The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $173.50 to $174.15, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F8The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $172.50 to $173.33, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
- F9The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $170.48 to $171.47, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.